
The Expanding Horizon of GLP-1 Receptor Agonists: From Diabetes Management to Cardiometabolic Renaissance
Abstract Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have revolutionized the treatment of type 2 diabetes mellitus (T2DM) and are rapidly expanding their therapeutic footprint. Initially developed to improve glycemic control, GLP-1RAs have demonstrated significant benefits in […]